These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Characterization of cytolytic effector cells in peripheral blood of healthy individuals and cancer patients. II. Cytotoxicity to allogeneic or autochthonous tumor cells in tissue culture. Pape GR, Troye M, Perlmann P. J Immunol; 1977 Jun; 118(6):1925-30. PubMed ID: 325130 [No Abstract] [Full Text] [Related]
6. Cellular cytotoxicity in transitional cell carcinoma of the human urinary bladder - a summary. Perlmann P, Troye M, Pape G, Blomgren H, Johansson B. Urol Res; 1978 Jun; 6(4):207-9. PubMed ID: 741533 [Abstract] [Full Text] [Related]
8. Lymphocyte antibody interaction in cytotoxicity against human transitional cell carcinoma. Hakala TR, Lange PH, Castro AE, Elliott AY, Fraley EE. J Urol; 1975 May; 113(5):663-7. PubMed ID: 1168732 [Abstract] [Full Text] [Related]
9. Immunologic evaluation of human bladder cancer: in vitro studies. Elhilali MM, Nayak SK. Cancer; 1975 Feb; 35(2):419-31. PubMed ID: 1111918 [Abstract] [Full Text] [Related]
10. Serum induced lymphoid cell mediated cytotoxicity to human transitional cell carcinomas of the genitourinary tract. Hakala TR, Lange PH. Science; 1974 May 17; 184(4138):795-7. PubMed ID: 4856602 [Abstract] [Full Text] [Related]
11. Cellular cytotoxicity in vitro in transitional cell carcinoma of the human urinary bladder: 51Cr-release assay. Troye M, Perlmann P, Larsson A, Blomgren H, Johansson B. Int J Cancer; 1977 Aug 15; 20(2):188-98. PubMed ID: 892930 [No Abstract] [Full Text] [Related]
12. Lymphocyte cytotoxicity in bladder cancer. No requirement for thymus-derived effector cells? O'Toole C, Perlmann P, Wigzell H, Unsgaard B, Zetterlund CG. Lancet; 1973 May 19; 1(7812):1085-8. PubMed ID: 4123535 [No Abstract] [Full Text] [Related]
13. Cell-mediated cytotoxicity against human bladder cancer. Bloom ET, Ossorio RC, Brosman SA. Int J Cancer; 1974 Sep 15; 14(3):326-34. PubMed ID: 4477556 [No Abstract] [Full Text] [Related]
14. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera. Schneider MU, Troye M, Paulie S, Perlmann P. Int J Cancer; 1980 Aug 15; 26(2):185-92. PubMed ID: 7203712 [Abstract] [Full Text] [Related]
15. Identification of complement-receptor lymphocytes (B cells) in lymph nodes and tumor infiltrates. Catalona WJ, Mann R, Nime F, Potvin C, Harty JI, Gomolka D, Eggleston JC. J Urol; 1975 Dec 15; 114(6):915-21. PubMed ID: 1081603 [Abstract] [Full Text] [Related]
16. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder. Bubeník J. Int Urol Nephrol; 1975 Dec 15; 7(4):297-302. PubMed ID: 1107249 [Abstract] [Full Text] [Related]
17. Cytotoxicity in vitro of blood lymphocytes from bladder cancer patients and controls to allogeneic or autologous tumor cells derived from established cell lines or short-term cultures. Troye M, Vilien M, Pape GR, Perlmann P. Int J Cancer; 1980 Jan 15; 25(1):33-43. PubMed ID: 7399743 [Abstract] [Full Text] [Related]
18. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24. Catalona WJ, Oldham RK, Djeu JY, Herberman RB, Cannon GB. Surg Forum; 1975 Jan 15; 26():122-4. PubMed ID: 56048 [No Abstract] [Full Text] [Related]
19. HLA antigen expression on urothelial cells: detection by antibody-dependent cell-mediated cytotoxicity. O'Toole CM, Tiptaft RC, Stevens A. Int J Cancer; 1982 Apr 15; 29(4):391-5. PubMed ID: 7085129 [Abstract] [Full Text] [Related]
20. Changes in cell-mediated cytotoxicity during the clinical course of patients with bladder carcinoma. Hakala TR, Lange PH, Elliott AY, Fraley EE. J Urol; 1976 Mar 15; 115(3):268-73. PubMed ID: 768528 [Abstract] [Full Text] [Related] Page: [Next] [New Search]